{
  "header": {
    "safetyreport": "1234567-8",
    "safetyreportversion": "17",
    "receivedate": "20041025",
    "receivedateformat": "102",
    "receiptdate": "20040224",
    "receiptdateformat": "102",
    "serious": "1",
    "seriousnesscongenitalanomali": "1",
    "seriousnessdeath": "1",
    "seriousnessdisabling": "1",
    "seriousnesshospitalization": "1",
    "seriousnesslifethreatening": "1",
    "seriousnessother": "1",
    "transmissiondate": "1",
    "transmissiondateformat": "1",
    "duplicate": "1",
    "companynumb": "200501050",
    "occurcountry": "US",
    "primarysourcecountry": "US",
    "primarysource": {
      "qualification": "1",
      "reportercountry": "UNITED STATES"
    },
    "reportduplicate": {
      "duplicatesource": "NOVARTIS",
      "duplicatenumb": "PHEH2006US00792"
    },
    "sender": {
      "sendertype": "2",
      "senderorganization": "FDA-Public Use"
    },
    "receiver": {
      "receivertype": "6",
      "receiverorganization": "FDA"
    }
  },
  "patient": {
    "patientonsetage": "59",
    "patientonsetageunit": "801",
    "patientsex": "2",
    "patientweight": "78",
    "patientdeath": {
      "patientdeathdate": "20030401",
      "patientdeathdateformat": "102"
    },
    "drug": [
      {
        "actiondrug": "1",
        "drugadditional": "1",
        "drugcumulativedosagenumb": "4100",
        "drugcumulativedosageunit": "003",
        "drugdosageform": "Tablet",
        "drugintervaldosagedefinition": "804",
        "drugintervaldosageunitnumb": "1",
        "drugrecurreadministration": "3",
        "drugseparatedosagenumb": "1",
        "drugstructuredosagenumb": "600",
        "drugstructuredosageunit": "003",
        "drugadministrationroute": "048",
        "drugauthorizationnumb": "021223",
        "drugbatchnumb": "020113A",
        "drugcharacterization": "1",
        "drugdoseagetext": "3.5 MG/KG, 1 IN 1 AS NECESSARY, INTRAVENOUS DRIP",
        "drugenddate": "20020920",
        "drugenddateformat": "102",
        "drugindication": "RHEUMATOID ARTHRITIS",
        "drugstartdate": "20020903",
        "drugstartdateformat": "102",
        "drugtreatmentduration": "1",
        "drugtreatmentdurationunit": "804",
        "medicinalproduct": "ASCORBIC ACID",
        "openfda": {
          "spl_id": [
            "f67ce1df-27ea-4c67-a8a3-daf3fb3b9a92",
            "72133842-ac3f-4a39-a825-38e01930a0a7"
          ],
          "product_ndc": [
            "0389-0486",
            "67457-118",
            "67457-303"
          ],
          "route": [
            "INTRAMUSCULAR",
            "INTRAVENOUS",
            "SUBCUTANEOUS"
          ],
          "substance_name": [
            "ASCORBIC ACID"
          ],
          "rxcui": [
            "308395"
          ],
          "spl_set_id": [
            "a6c36a36-28ee-4a1b-86fe-98ef94064b68",
            "d05200cb-cf29-4bc7-bf0c-b42ab2d20958"
          ],
          "package_ndc": [
            "67457-118-50",
            "0389-0486-50",
            "67457-303-50"
          ],
          "product_type": [
            "HUMAN PRESCRIPTION DRUG"
          ],
          "generic_name": [
            "ASCORBIC ACID"
          ],
          "manufacturer_name": [
            "The Torrance Company",
            "Mylan Institutional LLC"
          ],
          "brand_name": [
            "ASCORBIC ACID"
          ]
        }
      }
    ],
    "reaction": [
      {
        "reactionmeddrapt": "Osteonecrosis of jaw",
        "reactionmeddraversionpt": "16.1",
        "reactionoutcome": "6"
      },
      {
        "reactionmeddrapt": "HYPERTENSION"
      },
      {
        "reactionmeddrapt": "POLYTRAUMATISM"
      }
    ]
  }
}
